These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 27527800)

  • 41. The molecular basis underpinning the potency and specificity of MAIT cell antigens.
    Awad W; Ler GJM; Xu W; Keller AN; Mak JYW; Lim XY; Liu L; Eckle SBG; Le Nours J; McCluskey J; Corbett AJ; Fairlie DP; Rossjohn J
    Nat Immunol; 2020 Apr; 21(4):400-411. PubMed ID: 32123373
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells.
    Reantragoon R; Corbett AJ; Sakala IG; Gherardin NA; Furness JB; Chen Z; Eckle SB; Uldrich AP; Birkinshaw RW; Patel O; Kostenko L; Meehan B; Kedzierska K; Liu L; Fairlie DP; Hansen TH; Godfrey DI; Rossjohn J; McCluskey J; Kjer-Nielsen L
    J Exp Med; 2013 Oct; 210(11):2305-20. PubMed ID: 24101382
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Human blood MAIT cell subsets defined using MR1 tetramers.
    Gherardin NA; Souter MN; Koay HF; Mangas KM; Seemann T; Stinear TP; Eckle SB; Berzins SP; d'Udekem Y; Konstantinov IE; Fairlie DP; Ritchie DS; Neeson PJ; Pellicci DG; Uldrich AP; McCluskey J; Godfrey DI
    Immunol Cell Biol; 2018 May; 96(5):507-525. PubMed ID: 29437263
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ligand-dependent downregulation of MR1 cell surface expression.
    Salio M; Awad W; Veerapen N; Gonzalez-Lopez C; Kulicke C; Waithe D; Martens AWJ; Lewinsohn DM; Hobrath JV; Cox LR; Rossjohn J; Besra GS; Cerundolo V
    Proc Natl Acad Sci U S A; 2020 May; 117(19):10465-10475. PubMed ID: 32341160
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Identification and Phenotype of MAIT Cells in Cattle and Their Response to Bacterial Infections.
    Edmans MD; Connelley TK; Jayaraman S; Vrettou C; Vordermeier M; Mak JYW; Liu L; Fairlie DP; Maze EA; Chrun T; Klenerman P; Eckle SBG; Tchilian E; Benedictus L
    Front Immunol; 2021; 12():627173. PubMed ID: 33777010
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.
    Chen Z; Wang H; D'Souza C; Sun S; Kostenko L; Eckle SB; Meehan BS; Jackson DC; Strugnell RA; Cao H; Wang N; Fairlie DP; Liu L; Godfrey DI; Rossjohn J; McCluskey J; Corbett AJ
    Mucosal Immunol; 2017 Jan; 10(1):58-68. PubMed ID: 27143301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. MR1-restricted T cells: the new dawn of cancer immunotherapy.
    Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L
    Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential antigenic requirements by diverse MR1-restricted T cells.
    Seneviratna R; Redmond SJ; McWilliam HE; Reantragoon R; Villadangos JA; McCluskey J; Godfrey DI; Gherardin NA
    Immunol Cell Biol; 2022 Feb; 100(2):112-126. PubMed ID: 34940995
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Endosomal MR1 Trafficking Plays a Key Role in Presentation of Mycobacterium tuberculosis Ligands to MAIT Cells.
    Harriff MJ; Karamooz E; Burr A; Grant WF; Canfield ET; Sorensen ML; Moita LF; Lewinsohn DM
    PLoS Pathog; 2016 Mar; 12(3):e1005524. PubMed ID: 27031111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD1, MR1, NKT, and MAIT: evolution and origins of non-peptidic antigen recognition by T lymphocytes.
    Zajonc DM; Flajnik MF
    Immunogenetics; 2016 Aug; 68(8):489-90. PubMed ID: 27480412
    [No Abstract]   [Full Text] [Related]  

  • 51. Engineering of Isogenic Cells Deficient for MR1 with a CRISPR/Cas9 Lentiviral System: Tools To Study Microbial Antigen Processing and Presentation to Human MR1-Restricted T Cells.
    Laugel B; Lloyd A; Meermeier EW; Crowther MD; Connor TR; Dolton G; Miles JJ; Burrows SR; Gold MC; Lewinsohn DM; Sewell AK
    J Immunol; 2016 Aug; 197(3):971-82. PubMed ID: 27307560
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Co-dependents: MR1-restricted MAIT cells and their antimicrobial function.
    Gold MC; Lewinsohn DM
    Nat Rev Microbiol; 2013 Jan; 11(1):14-9. PubMed ID: 23178389
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MR1-restricted mucosal associated invariant T (MAIT) cells in the immune response to Mycobacterium tuberculosis.
    Gold MC; Napier RJ; Lewinsohn DM
    Immunol Rev; 2015 Mar; 264(1):154-66. PubMed ID: 25703558
    [TBL] [Abstract][Full Text] [Related]  

  • 54. MR1 presents microbial vitamin B metabolites to MAIT cells.
    Kjer-Nielsen L; Patel O; Corbett AJ; Le Nours J; Meehan B; Liu L; Bhati M; Chen Z; Kostenko L; Reantragoon R; Williamson NA; Purcell AW; Dudek NL; McConville MJ; O'Hair RA; Khairallah GN; Godfrey DI; Fairlie DP; Rossjohn J; McCluskey J
    Nature; 2012 Nov; 491(7426):717-23. PubMed ID: 23051753
    [TBL] [Abstract][Full Text] [Related]  

  • 55. MAIT Cells Are Major Contributors to the Cytokine Response in Group A Streptococcal Toxic Shock Syndrome.
    Emgård J; Bergsten H; McCormick JK; Barrantes I; Skrede S; Sandberg JK; Norrby-Teglund A
    Proc Natl Acad Sci U S A; 2019 Dec; 116(51):25923-25931. PubMed ID: 31772015
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drugs and drug-like molecules can modulate the function of mucosal-associated invariant T cells.
    Keller AN; Eckle SB; Xu W; Liu L; Hughes VA; Mak JY; Meehan BS; Pediongco T; Birkinshaw RW; Chen Z; Wang H; D'Souza C; Kjer-Nielsen L; Gherardin NA; Godfrey DI; Kostenko L; Corbett AJ; Purcell AW; Fairlie DP; McCluskey J; Rossjohn J
    Nat Immunol; 2017 Apr; 18(4):402-411. PubMed ID: 28166217
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Opsonization-Enhanced Antigen Presentation by MR1 Activates Rapid Polyfunctional MAIT Cell Responses Acting as an Effector Arm of Humoral Antibacterial Immunity.
    Boulouis C; Gorin JB; Dias J; Bergman P; Leeansyah E; Sandberg JK
    J Immunol; 2020 Jul; 205(1):67-77. PubMed ID: 32434941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Functionally diverse human T cells recognize non-microbial antigens presented by MR1.
    Lepore M; Kalinichenko A; Calogero S; Kumar P; Paleja B; Schmaler M; Narang V; Zolezzi F; Poidinger M; Mori L; De Libero G
    Elife; 2017 May; 6():. PubMed ID: 28518056
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Alternative splicing of MR1 regulates antigen presentation to MAIT cells.
    Narayanan GA; Nellore A; Tran J; Worley AH; Meermeier EW; Karamooz E; Huber ME; Kurapova R; Tafesse FG; Harriff MJ; Lewinsohn DM
    Sci Rep; 2020 Sep; 10(1):15429. PubMed ID: 32963314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis.
    Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S
    Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.